Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer

eClinicalMedicine(2023)

Cited 1|Views30
No score
Abstract
Bayer HealthCare.
More
Translated text
Key words
Clinical outcomes,Radium-223,Metastatic castration-resistant prostate cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined